Advisor Group Holdings, Inc. Oncolytics Biotech Inc Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 8,497 shares of ONCY stock, worth $7,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,497

Previous 8,497 -0.0%

Holding current value

$7,562

Previous $8,000 12.5%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.99 - $1.24 $4,793 - $6,004	-4,842 Reduced 36.3%	8,497 $8,000
Q1 2024 May 10, 2024	BUY	$0.89 - $1.36 $3,673 - $5,612	4,127 Added 44.8%	13,339 $14,000
Q4 2023 Feb 12, 2024	SELL	$1.22 - $2.09 $610 - $1,045	-500 Reduced 5.15%	9,212 $12,000
Q3 2023 Nov 13, 2023	SELL	$1.98 - $3.24 $5,294 - $8,663	-2,674 Reduced 21.59%	9,712 $21,000
Q2 2023 Aug 10, 2023	SELL	$1.11 - $2.74 $250,522 - $618,407	-225,696 Reduced 94.8%	12,386 $32,000
Q1 2023 May 12, 2023	BUY	$1.2 - $1.91 $275,700 - $438,822	229,750 Added 2757.44%	238,082 $285,000
Q4 2022 Feb 10, 2023	BUY	$1.17 - $2.12 $985 - $1,785	842 Added 11.24%	8,332 $13,000
Q2 2022 Aug 10, 2022	SELL	$0.85 - $1.59 $447 - $837	-527 Reduced 6.57%	7,490 $8,000
Q1 2022 May 04, 2022	BUY	$1.31 - $2.02 $6,622 - $10,211	5,055 Added 170.66%	8,017 $11,000
Q3 2021 Nov 05, 2021	SELL	$1.93 - $2.77 $2,895 - $4,155	-1,500 Reduced 33.62%	2,962 $6,000
Q2 2021 Aug 02, 2021	BUY	$2.6 - $4.64 $1,300 - $2,320	500 Added 12.62%	4,462 $12,000
Q1 2021 May 13, 2021	BUY	$2.32 - $4.11 $2,320 - $4,110	1,000 Added 33.76%	3,962 $16,000
Q4 2020 Feb 10, 2021	SELL	$1.71 - $4.03 $114 - $270	-67 Reduced 2.21%	2,962 $7,000
Q2 2020 Aug 14, 2020	SELL	$1.33 - $2.76 $9,336 - $19,375	-7,020 Reduced 69.86%	3,029 $6,000
Q1 2020 May 18, 2020	BUY	$0.98 - $4.28 $9,848 - $43,009	10,049 New	10,049 $13,000

Others Institutions Holding ONCY

# of Institutions

Shares Held

1.18M

Call Options Held

Put Options Held

View Full List

About ONCOLYTICS BIOTECH INC

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $51.5M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

More about ONCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Oncolytics Biotech Inc Transaction History